WallStreetZenWallStreetZen

NASDAQ: KTTA
Pasithea Therapeutics Corp Stock Ownership - Who owns Pasithea Therapeutics?

Insider buying vs selling

Have Pasithea Therapeutics Corp insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Alfred J. NovakDirector2024-06-132,750$5.62
$15.46kBuy
Alfred J. NovakDirector2024-06-12750$5.61
$4.21kBuy

1 of 1

KTTA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KTTA insiders and whales buy or sell their stock.

KTTA Shareholders

What type of owners hold Pasithea Therapeutics Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Pd Joint Holdings LLC Series 2016a249.86%2,608,696$10.93MInsider
Eric Shahinian171.29%1,788,415$7.49MInsider
Lawrence Steinman122.80%1,282,174$5.37MInsider
Israel Maxx Abramowitz100.72%1,051,575$4.41MInsider
Avi Geller99.10%1,034,702$4.34MInsider
Dean Lazer86.45%902,600$3.78MInsider
Eric Lazer86.45%902,600$3.78MInsider
Tiago Marques78.46%819,206$3.43MInsider
Yassine Bendiabdallah28.73%300,000$1.26MInsider
David Delaney21.79%227,521$953.31kInsider

1 of 2

KTTA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KTTA0.27%99.73%Net BuyingNet Buying
RNAZ1.52%20.09%Net Buying
NLSP23.90%0.00%
SONN10.88%89.12%
LIXT3.14%96.86%Net Buying

Pasithea Therapeutics Stock Ownership FAQ

Who owns Pasithea Therapeutics?

Pasithea Therapeutics (NASDAQ: KTTA) is owned by 2.87% institutional shareholders, 1,050.78% Pasithea Therapeutics insiders, and 0.00% retail investors. Pd Joint Holdings LLC Series 2016a is the largest individual Pasithea Therapeutics shareholder, owning 2.61M shares representing 249.86% of the company. Pd Joint Holdings LLC Series 2016a's Pasithea Therapeutics shares are currently valued at $11.09M.

If you're new to stock investing, here's how to buy Pasithea Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.